Author:
Kopp Tamara,Riedl Elisabeth,Bangert Christine,Bowman Edward P.,Greisenegger Elli,Horowitz Ann,Kittler Harald,Blumenschein Wendy M.,McClanahan Terrill K.,Marbury Thomas,Zachariae Claus,Xu Danlin,Hou Xiaoli Shirley,Mehta Anish,Zandvliet Anthe S.,Montgomery Diana,van Aarle Frank,Khalilieh Sauzanne
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Schön, M. P. & Boehncke, W. H. Psoriasis. N. Engl. J. Med. 352, 1899–1912 (2005)
2. Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866–873 (2007)
3. Krueger, G. et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch. Dermatol. 137, 280–284 (2001)
4. Leonardi, C. L. et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371, 1665–1674 (2008)
5. Papp, K. A. et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371, 1675–1684 (2008)
Cited by
189 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献